Back to Agenda
Session 5, Part 2: The Paradigm Shift: from Treatment to Prevention
Session Chair(s)
Michael Forstner, PhD, MPH, MSc
Managing Director, Head of Pharmacoepidemiology Practice, Switzerland
Maria Raad
Vice President, Customer and Digital Strategy, Janssen EMEA Commercial, Switzerland
Session 5, Part 2: The Paradigm Shift: from Treatment to Prevention
Speaker(s)
Christian Gossens, PhD
Global Area Head, Digital Biomarker Informatics, F. Hoffmann-La Roche Ltd., Switzerland
Setting the Scene: Digital Biomarkers in Clinical Research from a Pharma Industry Perspective
Foteini Orfaniotou
Group Digital Health Leader, F. Hoffmann-La Roche Ltd., Switzerland
Panel Discussion: Where are we with Digital Biomarkers for Disease Monitoring?
Christian Gossens, PhD
Global Area Head, Digital Biomarker Informatics, F. Hoffmann-La Roche Ltd., Switzerland
Trishna Bharadia
Patient Advocate, International Speaker, Writer, Advisor and Content Reviewer, The Spark Global, United Kingdom
Marcus D'Souza
Head Neurostatus-UHB, University Hospital Basel, Switzerland
Have an account?